James D. Marks
Direttore/Membro del Consiglio presso Silver Creek Pharmaceuticals, Inc.
Profilo
James D.
Marks is the founder of MIGS LLC, which was founded in 2013.
Dr. Marks is also the founder of Hermes Biosciences, Inc. Currently, Dr. Marks is a Director at Silver Creek Pharmaceuticals, Inc.
Posizioni attive di James D. Marks
| Società | Posizione | Inizio |
|---|---|---|
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di James D. Marks
| Società | Posizione | Fine |
|---|---|---|
Hermes Biosciences, Inc.
 Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Fondatore | - |
MIGS LLC
 MIGS LLC BiotechnologyHealth Technology MIGS LLC specializes in antibody production. It provides synthesis and cloning, purification, production, characterization, high throughput production, antibody humanization, and engineering. The company was founded by Michael Feldhaus, James D. Marks, and Jose Varghese in 2013 and is headquartered in Lebanon, NH. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
MIGS LLC
MIGS LLC BiotechnologyHealth Technology MIGS LLC specializes in antibody production. It provides synthesis and cloning, purification, production, characterization, high throughput production, antibody humanization, and engineering. The company was founded by Michael Feldhaus, James D. Marks, and Jose Varghese in 2013 and is headquartered in Lebanon, NH. | Health Technology |
Hermes Biosciences, Inc.
Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Health Technology |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- James D. Marks
